Royalty Pharma (RPRX) Income Statement (2019 - 2026)
Income Statement report data from Jun 30, 2019 to Mar 31, 2026 for Royalty Pharma (RPRX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||
Total Revenue | 631M (+1.38%) | 622M (+2.08%) | 609M (+5.29%) | 579M (+1.83%) | 568M (-4.28%) | 594M (+5.13%) | 565M (+5.10%) | 537M (-5.41%) | 568M (-4.71%) | 596M (+11.14%) | 536M (-0.35%) | 538M (-21.31%) | 684M (+20.90%) | 566M (-1.34%) | 573M (+7.00%) | 536M (-4.64%) | 562M (-2.37%) | 576M (-1.72%) | 586M (+5.55%) | 555M (-3.15%) | 573M (+6.43%) | 538M (+5.38%) | 511M (+2.01%) | 501M (+7.88%) | 464M (+1.46%) | 458M |
Operating Expenses | ||||||||||||||||||||||||||
Research And Development | 40M (-21.21%) | 51M (0.00%) | 51M (-83.19%) | 301M (+495.05%) | 51M (+10000.00%) | 500K (0.00%) | 500K (0.00%) | 500K (0.00%) | 500K (0.00%) | 500K (-99.01%) | 51M (+10000.00%) | 500K (0.00%) | 500K (-99.01%) | 51M (+98.04%) | 26M (+4080.33%) | 610K (-99.39%) | 101M (-3.20%) | 104M (+14.72%) | 91M (+2800.64%) | 3.12M (+18.18%) | 2.64M (-48.24%) | 5.10M (-11.76%) | 5.78M (-24.35%) | 7.64M (-66.37%) | 23M (+5.87%) | 21M |
Selling General And Administrative | 159M (-2.91%) | 164M (+38.36%) | 119M (-33.95%) | 180M (+62.38%) | 111M (+63.80%) | 68M (+19.16%) | 57M (+3.67%) | 55M (-5.10%) | 58M (-2.60%) | 59M (+3.42%) | 57M (+20.16%) | 48M (-44.42%) | 86M (+17.03%) | 73M (+44.47%) | 51M (-2.22%) | 52M (+0.58%) | 52M (+11.66%) | 46M (-5.00%) | 49M (+8.17%) | 45M (+4.08%) | 43M (-14.92%) | 51M (+18.53%) | 43M (+12.42%) | 38M (+48.71%) | 26M (-15.65%) | 30M |
Operating Expenses | 68M (-71.09%) | 234M (+28.26%) | 182M (-50.62%) | 369M (+982.68%) | 34M (-85.32%) | 232M | -170.38M | 268M (-58.30%) | 642M | -16.83M | 385M (+33.01%) | 289M (+41.15%) | 205M (-80.45%) | 1.05B (+174.99%) | 381M (+141.05%) | 158M (-53.80%) | 342M (-18.93%) | 422M (+49.36%) | 283M | -189.99M | 344M (+1135.11%) | 28M (-72.61%) | 102M (-27.15%) | 139M | -68.22M | 130M |
Depreciation And Amortization | 1.17M (-69.61%) | 3.85M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | ||||||||||||||||||||||||||
Operating Income | 563M (+44.97%) | 388M (-9.08%) | 427M (+103.60%) | 210M (-60.72%) | 534M (+47.76%) | 362M (-50.82%) | 735M (+172.62%) | 270M | -73.77M | 613M (+304.71%) | 151M (-39.14%) | 249M (-48.05%) | 479M | -482.65M | 192M (-49.12%) | 378M (+71.94%) | 220M (+43.21%) | 153M (-49.37%) | 303M (-59.32%) | 745M (+224.88%) | 229M (-55.09%) | 511M (+24.73%) | 409M (+13.26%) | 361M (-32.13%) | 533M (+62.42%) | 328M |
Ebit | 563M (+44.97%) | 388M (-9.08%) | 427M (+103.60%) | 210M (-60.72%) | 534M (+47.76%) | 362M (-50.82%) | 735M (+172.62%) | 270M | -73.77M | 613M (+304.71%) | 151M (-39.14%) | 249M (-48.05%) | 479M | -482.65M | 192M (-49.12%) | 378M (+71.94%) | 220M (+43.21%) | 153M (-49.37%) | 303M (-59.32%) | 745M (+224.88%) | 229M (-55.09%) | 511M (+24.73%) | 409M (+13.26%) | 361M (-32.13%) | 533M (+62.42%) | 328M |
EBITDA | 564M (+0.29%) | 563M (+52.96%) | 368M (+272.10%) | 99M (-81.50%) | 534M (+10.84%) | 482M (-21.06%) | 610M (+304.24%) | 151M (+208.14%) | 49M (-93.11%) | 712M (+502.39%) | 118M (-56.97%) | 275M (-29.18%) | 388M | -409.13M | 190M (-46.05%) | 351M (+255.67%) | 99M (+80.07%) | 55M (-62.48%) | 146M (-69.41%) | 478M (+348.89%) | 107M (-66.92%) | 322M (-32.37%) | 476M (+281.56%) | 125M (-73.88%) | 478M (+116.31%) | 221M |
Other Income / Expenses | ||||||||||||||||||||||||||
Interest Expense | 94M (-0.48%) | 94M (+18.36%) | 80M (+15.86%) | 69M (+5.23%) | 65M (-0.76%) | 66M (-1.13%) | 67M (+35.71%) | 49M (+10.81%) | 44M (-6.41%) | 47M (+2.67%) | 46M (-1.96%) | 47M (0.00%) | 47M (-0.02%) | 47M (-0.04%) | 47M (+0.02%) | 47M (-0.19%) | 47M (+0.19%) | 47M (+5.96%) | 44M (+18.43%) | 37M (+0.03%) | 37M (+19.02%) | 31M (-8.04%) | 34M (-36.19%) | 54M (-22.12%) | 69M (-0.53%) | 69M |
Net Interest Income | - | - | - | - | - | 44M | - | - | -44.23M (-6.39%) | -47.25M (+2.65%) | -46.03M (-1.96%) | -46.95M (0.00%) | -46.95M (0.00%) | -46.95M (-0.06%) | -46.98M (+0.02%) | -46.97M (-0.19%) | -47.06M (+0.19%) | -46.97M (+5.96%) | -44.33M (+18.43%) | -37.43M (+0.05%) | -37.41M (+18.99%) | -31.44M (-8.04%) | -34.19M (-36.19%) | -53.58M (-22.12%) | -68.80M (-0.53%) | -69.17M |
Other Non Operating Income | -2.20M (-84.67%) | -14.35M (+814.01%) | -1.57M (+1.95%) | -1.54M (-49.67%) | -3.06M (+100.00%) | -1.53M (-7.27%) | -1.65M | 6.00M | -3.68M (-83.07%) | -21.74M (+1171.35%) | -1.71M | 1.09M | -2.81M (-80.95%) | -14.75M (+36.57%) | -10.80M (+948.54%) | -1.03M (-41.48%) | -1.76M (-69.01%) | -5.68M (+618.99%) | -790.00K (+618.18%) | -110.00K | 40K | -23.34M | 260K | -5.92M | 230K | -40.00K |
Net Income | ||||||||||||||||||||||||||
Income Before Tax | 468M (+31.94%) | 355M (-20.10%) | 444M (+390.08%) | 91M (-79.14%) | 434M (+29.93%) | 334M (-58.54%) | 806M (+314.84%) | 194M | -4.27M | 718M (+487.80%) | 122M (-65.25%) | 351M (-30.99%) | 509M | -610.03M | 220M (-55.16%) | 492M (+283.82%) | 128M (+138.64%) | 54M (-75.80%) | 222M (-72.51%) | 807M (+407.46%) | 159M (-74.53%) | 624M (+3.70%) | 602M (+451.77%) | 109M (-75.21%) | 440M (+146.14%) | 179M |
Net Income From Continuing Operations | 295M (+38.22%) | 213M (-26.03%) | 288M (+855.00%) | 30M (-87.39%) | 239M (+14.96%) | 208M (-61.73%) | 544M (+433.32%) | 102M (+2033.89%) | 4.78M (-99.03%) | 494M (+585.54%) | 72M (-68.32%) | 228M (-33.20%) | 341M | -456.08M | 143M (-53.15%) | 305M (+488.29%) | 52M (+555.19%) | 7.90M (-92.25%) | 102M (-76.88%) | 441M (+537.70%) | 69M (-76.22%) | 291M (-34.26%) | 442M (+520.54%) | 71M (-82.58%) | 409M (+169.58%) | 152M |
Net Income | 295M (+38.22%) | 213M (-26.03%) | 288M (+855.00%) | 30M (-87.39%) | 239M (+14.96%) | 208M (-61.73%) | 544M (+433.32%) | 102M (+2033.89%) | 4.78M (-99.03%) | 494M (+585.54%) | 72M (-68.32%) | 228M (-33.20%) | 341M | -456.08M | 143M (-53.15%) | 305M (+488.29%) | 52M (+555.19%) | 7.90M (-92.25%) | 102M (-76.88%) | 441M (+537.70%) | 69M (-76.22%) | 291M (-34.26%) | 442M (+520.54%) | 71M (-82.58%) | 409M (+169.58%) | 152M |
Comprehensive Income Net Of Tax | - | - | - | - | - | 859M | - | - | - | 1.13B (+1473.75%) | 72M (-68.32%) | 228M (-33.20%) | 341M (+1251.69%) | 25M (-82.76%) | 146M (-52.12%) | 305M (+543.55%) | 47M (-92.06%) | 598M (+538.44%) | 94M (-78.57%) | 437M (+586.36%) | 64M (-78.39%) | 294M (-34.19%) | 447M (+278.00%) | 118M (-70.97%) | 408M (+160.93%) | 156M |